Ignacio Matos

6PUBLICATIONS
67CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 13, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Dec 07, 2023
Fcγ receptors and immunomodulatory antibodies in cancer.

Felipe Galvez-Cancino, Alexander P Simpson, Cristobal Costoya

|Sep 01, 2023
Druggable Targets in Cytokine Release Syndromes.

Carlos Luri-Rey, Iñaki Eguren-Santamaria, Ignacio Matos

|Mar 11, 2023
Low Risk of Hyperprogression with First-Line Chemoimmunotherapy for Advanced Non-Small Cell Lung Cancer: Pooled Analysis of 7 Clinical Trials.

Lee X Li, Federico Cappuzzo, Ignacio Matos

|Feb 07, 2023
Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero

|Jan 26, 2021
A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors.

Marta Ligero, Alonso Garcia-Ruiz, Cristina Viaplana

Pageof 1

Frequent Collaborators

2 joint publications

Maria Ochoa-de-Olza

2 joint publications

Eva Muñoz-Couselo

2 joint publications

Elena Garralda

1 joint publications

Marta Ligero